Roman A. Naydenov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Roman A. Naydenov has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Oleg Viktorovich Krestyaninov
Meshalkin National Medical Research Center; Novosibirsk State Medical University
10 shared publications - Aleksei A. Baranov
Meshalkin National Medical Research Center
8 shared publications - Aram G. Badoyan
Meshalkin National Medical Research Center
8 shared publications - Dmitrii Khelimskii
Meshalkin National Medical Research Center
8 shared publications - Aryuna Yu. Tsydenova
Meshalkin National Medical Research Center; Novosibirsk State Medical University
6 shared publications - Sh. Sh. Zainobidinov
Meshalkin National Medical Research Center
4 shared publications
Latest Publications
- Open Access
- 26 November 2025
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 4,p. 48-60
Comparative evaluation of long-term results of percutaneous coronary intervention and optimal medical therapy in patients with multivessel coronary artery disease not eligible for coronary artery bypass graft
Aim. To evaluate the long-term results of percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT) and OMT alone in patients with stable chronic coronary syndrome (CCS) and multivessel coronary artery disease who were not eligible for coronary artery bypass graft surgery (CABG). Material and methods. This retrospective study included 374 patients with stable CCS and multivessel coronary artery disease, not eligible for CABG, hospitalized between 2013 and 2022. Patients were divided into 2 groups: Group 1 conservative therapy (OMT alone) and Group 2 invasive strategy (PCI+OMT). The primary composite endpoint of the study was the incidence of major adverse cardiovascular and cerebrovascular events (MACCE). In order to balance the groups according to their initial characteristics, Propensity score matching (PSM) was performed. Results. Out of 374 patients, 321 patients were selected after PSM: 107 into the first group and 214 into the second group. The median age of the study patients was 69 [61; 76] years in group one and 66 [60; 74] years in group two (p=0,212). The median SYNTAX score was 32 [24; 40] versus 30 [24; 37], respectively (p=0,239). Long-term outcome analysis was performed in 306 patients out of 321 (95,3%). The incidence of the primary endpoint (MAСCE) in the conservative strategy group was 64,1% versus 51,8% in the invasive strategy group, p=0,034. Conclusion . Invasive strategy (PCI+OMT) in patients with CCS and multivessel coronary lesions and not eligible for CABG is accompanied by a high rate of procedural success and a low rate of in-hospital complications. Myocardial revascularization by PCI in this cohort of patients leads to statistically significant reduction in the incidence of MACCE and cardiac mortality in the long-term follow-up period in comparison with conservative therapy.
- 26 November 2025
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 4,p. 48-60
Open AccessComparative evaluation of long-term results of percutaneous coronary intervention and optimal medical therapy in patients with multivessel coronary artery disease not eligible for coronary artery bypass graft
Aim. To evaluate the long-term results of percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT) and OMT alone in patients with stable chronic coronary syndrome (CCS) and multivessel coronary artery disease who were not eligible for coronary artery bypass graft surgery (CABG). Material and methods. This retrospective study included 374 patients with stable CCS and multivessel coronary artery disease, not eligible for CABG, hospitalized between 2013 and 2022. Patients were divided into 2 groups: Group 1 conservative therapy (OMT alone) and Group 2 invasive strategy (PCI+OMT). The primary composite endpoint of the study was the incidence of major adverse cardiovascular and cerebrovascular events (MACCE). In order to balance the groups according to their initial characteristics, Propensity score matching (PSM) was performed. Results. Out of 374 patients, 321 patients were selected after PSM: 107 into the first group and 214 into the second group. The median age of the study patients was 69 [61; 76] years in group one and 66 [60; 74] years in group two (p=0,212). The median SYNTAX score was 32 [24; 40] versus 30 [24; 37], respectively (p=0,239). Long-term outcome analysis was performed in 306 patients out of 321 (95,3%). The incidence of the primary endpoint (MAСCE) in the conservative strategy group was 64,1% versus 51,8% in the invasive strategy group, p=0,034. Conclusion . Invasive strategy (PCI+OMT) in patients with CCS and multivessel coronary lesions and not eligible for CABG is accompanied by a high rate of procedural success and a low rate of in-hospital complications. Myocardial revascularization by PCI in this cohort of patients leads to statistically significant reduction in the incidence of MACCE and cardiac mortality in the long-term follow-up period in comparison with conservative therapy.
- Open Access
- 18 November 2025
- Published by Consilium Medicum in Consilium Medicum
- Vol. 27 (10) , 577-583
The role of percutaneous coronary intervention in the treatment of patients with multivessel coronary artery disease who are turned down for coronary artery bypass grafting (literature review)
Despite the development of modern technologies in the field of healthcare and the wide application of modern diagnostic and treatment methods, mortality from ischemic heart disease remains the leading cause of death among diseases. It is known that coronary artery bypass grafting in combination with optimal medical therapy is the gold standard for treating patients with multivessel coronary artery disease. However, for several decades now, percutaneous coronary intervention has proven to be an alternative method of myocardial revascularization for patient with multivessel coronary artery disease and low or intermediate risk. Nevertheless, despite accumulated experience in treating patients with ischemic heart disease, the choice of revascularization method for patients with complex coronary artery disease and high surgical risk (not eligible for CABG) remains debatable. In this review article, the authors described the main factors influencing the choice of myocardial revascularization strategy and demonstrated the results of clinical studies dedicated to studying this issue.
- 18 November 2025
- Published by Consilium Medicum in Consilium Medicum
- Vol. 27 (10) , 577-583
Open AccessThe role of percutaneous coronary intervention in the treatment of patients with multivessel coronary artery disease who are turned down for coronary artery bypass grafting (literature review)
Despite the development of modern technologies in the field of healthcare and the wide application of modern diagnostic and treatment methods, mortality from ischemic heart disease remains the leading cause of death among diseases. It is known that coronary artery bypass grafting in combination with optimal medical therapy is the gold standard for treating patients with multivessel coronary artery disease. However, for several decades now, percutaneous coronary intervention has proven to be an alternative method of myocardial revascularization for patient with multivessel coronary artery disease and low or intermediate risk. Nevertheless, despite accumulated experience in treating patients with ischemic heart disease, the choice of revascularization method for patients with complex coronary artery disease and high surgical risk (not eligible for CABG) remains debatable. In this review article, the authors described the main factors influencing the choice of myocardial revascularization strategy and demonstrated the results of clinical studies dedicated to studying this issue.
- Open Access
- 20 May 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (4) , 6128
Immediate and short-term outcomes of percutaneous coronary intervention in patients with stable and multivessel coronary artery disease, intolerant to coronary artery bypass grafting
Aim. To evaluate immediate angiographic and clinical outcomes of percutaneous coronary intervention (PCI) in patients with stable and multivessel coronary artery disease (CAD), intolerant to coronary artery bypass grafting.Material and methods. This retrospective study included 307 patients with multivessel CAD who underwent myocardial revascularization using PCI between 2013 and 2022. Mortality, complications, and clinical parameters after the procedure were assessed in the early postoperative period.Results. Revascularization was successful in 94,9% of patients, The mean surgery duration was 59,0±28,9 min. The incidence of major adverse cardiac and cerebrovascular events was 3,1%. Complete revascularization was achieved in 54 (17,6%) patients. There were following independent predictors of incomplete myocardial revascularization according to multivariate regression analysis: high EuroSCORE II (odds ratio (OR) 0,83, 95% confidence interval (CI): 0,68-1,0; p=0,047), SYNTAX (OR 0,93, 95% CI: 0,89-0,97; p=0,001), and J-CTO (OR 0,68, 95% CI: 0,49-0,94; p=0,0018) scores.Conclusion. PCI in patients with multivessel CAD and intolerance to coronary artery bypass grafting is a safe procedure with low inhospital mortality and postoperative complications. PCI in this cohort of patients is associated with a high rate of procedural success. Additional studies, including randomized trials, are needed to assess the long-term prognosis in this cohort of patients.
- 20 May 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (4) , 6128
Open AccessImmediate and short-term outcomes of percutaneous coronary intervention in patients with stable and multivessel coronary artery disease, intolerant to coronary artery bypass grafting
Aim. To evaluate immediate angiographic and clinical outcomes of percutaneous coronary intervention (PCI) in patients with stable and multivessel coronary artery disease (CAD), intolerant to coronary artery bypass grafting.Material and methods. This retrospective study included 307 patients with multivessel CAD who underwent myocardial revascularization using PCI between 2013 and 2022. Mortality, complications, and clinical parameters after the procedure were assessed in the early postoperative period.Results. Revascularization was successful in 94,9% of patients, The mean surgery duration was 59,0±28,9 min. The incidence of major adverse cardiac and cerebrovascular events was 3,1%. Complete revascularization was achieved in 54 (17,6%) patients. There were following independent predictors of incomplete myocardial revascularization according to multivariate regression analysis: high EuroSCORE II (odds ratio (OR) 0,83, 95% confidence interval (CI): 0,68-1,0; p=0,047), SYNTAX (OR 0,93, 95% CI: 0,89-0,97; p=0,001), and J-CTO (OR 0,68, 95% CI: 0,49-0,94; p=0,0018) scores.Conclusion. PCI in patients with multivessel CAD and intolerance to coronary artery bypass grafting is a safe procedure with low inhospital mortality and postoperative complications. PCI in this cohort of patients is associated with a high rate of procedural success. Additional studies, including randomized trials, are needed to assess the long-term prognosis in this cohort of patients.
- Open Access
- 30 June 2024
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 13 (2) , 101-115
CORONARY ARTERY CALCIFICATION: INTRACORONARY IMAGING, CONTEMPORARY TECHNOLOGIES OF TREATMENT
HighlightsThis review presents current state-of-the-art of diagnosis and treatment of coronary artery calcification. AbstractCoronary artery calcification occurs in about one third of all coronary artery lesions in patients with coronary artery diseases and is a problem in interventional cardiology due to technical difficulties. Percutaneous coronary intervention for coronary artery calcification is associated with a high risk of perioperative complications, adverse cardiovascular events in early and long-term follow-up compared with the results of treatment of patients without arterial calcification. One of the most important predictors of a favorable outcome after implantation of a drug-eluting stent is the optimal cross-sectional area of coronary stent. Intravascular imaging plays an important role in lesion assessment, selection of instruments and optimization of stent implantation, contemporary technologies modification of severe coronary artery calcification, as well as their combination, will probably lead to better procedural success and long-term results.
- 30 June 2024
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 13 (2) , 101-115
Open AccessCORONARY ARTERY CALCIFICATION: INTRACORONARY IMAGING, CONTEMPORARY TECHNOLOGIES OF TREATMENT
HighlightsThis review presents current state-of-the-art of diagnosis and treatment of coronary artery calcification. AbstractCoronary artery calcification occurs in about one third of all coronary artery lesions in patients with coronary artery diseases and is a problem in interventional cardiology due to technical difficulties. Percutaneous coronary intervention for coronary artery calcification is associated with a high risk of perioperative complications, adverse cardiovascular events in early and long-term follow-up compared with the results of treatment of patients without arterial calcification. One of the most important predictors of a favorable outcome after implantation of a drug-eluting stent is the optimal cross-sectional area of coronary stent. Intravascular imaging plays an important role in lesion assessment, selection of instruments and optimization of stent implantation, contemporary technologies modification of severe coronary artery calcification, as well as their combination, will probably lead to better procedural success and long-term results.
- 22 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 17 (5)
Predictors and impact of myocardial injury (VARC-3 criteria) after transcatheter aortic valve implantation
Objective. To determine the factors associated with periprocedural increase in high-sensitive troponin I (hsTrI) after transcatheter aortic valve implantation (TAVI), as well as to evaluate prognostic significance of periprocedural myocardial injury (PMI) on survival of patients after TAVI. Material and methods. A retrospective study included 149 patients who underwent TAVI for severe aortic stenosis. Analysis included patients with available assessment of hsTrI before and after TAVI. According to postoperative hsTrI (VARC-3 criteria), all patients were divided into 2 groups: group 1 — patients with 70 times excess of the upper limit of normal (ULN) hsTrI («hsTrI≥70×ULN»), group 2 — patients with hsTrI <70xULN («hsTrI<70×ULN»). Results. PMI occurred in 18.8% of patients. According to multivariate regression analysis, independent predictors of 70-fold increase in hsTrI were age (OR 1.13, 95% CI 1.01—1.26, p=0.03), female sex (OR 15.6, 95% CI 2.57—95.20, p=0.003) and bioprosthesis implantation depth (OR 1.46, 95% CI 1.10—1.94, p=0.009). There were no significant differences in survival rate (85.7% vs. 90.9%, plog-rank=0.48). Conclusion. Age, female gender and bioprosthesis implantation depth were independent predictors of PMI after TAVI. Myocardial injury after TAVI does not affect long-term survival of patients.
- 22 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 17 (5)
Predictors and impact of myocardial injury (VARC-3 criteria) after transcatheter aortic valve implantation
Objective. To determine the factors associated with periprocedural increase in high-sensitive troponin I (hsTrI) after transcatheter aortic valve implantation (TAVI), as well as to evaluate prognostic significance of periprocedural myocardial injury (PMI) on survival of patients after TAVI. Material and methods. A retrospective study included 149 patients who underwent TAVI for severe aortic stenosis. Analysis included patients with available assessment of hsTrI before and after TAVI. According to postoperative hsTrI (VARC-3 criteria), all patients were divided into 2 groups: group 1 — patients with 70 times excess of the upper limit of normal (ULN) hsTrI («hsTrI≥70×ULN»), group 2 — patients with hsTrI <70xULN («hsTrI<70×ULN»). Results. PMI occurred in 18.8% of patients. According to multivariate regression analysis, independent predictors of 70-fold increase in hsTrI were age (OR 1.13, 95% CI 1.01—1.26, p=0.03), female sex (OR 15.6, 95% CI 2.57—95.20, p=0.003) and bioprosthesis implantation depth (OR 1.46, 95% CI 1.10—1.94, p=0.009). There were no significant differences in survival rate (85.7% vs. 90.9%, plog-rank=0.48). Conclusion. Age, female gender and bioprosthesis implantation depth were independent predictors of PMI after TAVI. Myocardial injury after TAVI does not affect long-term survival of patients.
- Open Access
- 6 July 2023
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 38 (2) , 98-103
Features of the management of elderly patients with non ST segment elevation myocardial infarction: analysis of risk factors, diagnosis and treatment strategy
Despite the technological developments in the healthcare industry, cardiovascular disease mortality occupies a leading place among the structure of general mortality of the population. The use of modern treatment methods, especially, percutaneous coronary intervention, provides timely assistance to patients with acute coronary syndrome and helps to reduce mortality frequency. Currently, clear algorithms for the management of patients with ST-segment elevation myocardial infarction have been developed. However, despite it, there are paradigms in the management of patients with non-ST-segment elevation myocardial infarction (NSTEMI). This is primarily due to the fact that the vast majority of patients with NSTEMI are elderly and senile persons. This review article presented the main factors that adversely affect short- and long-term prognosis and results of clinical studies dedicated to the study of this problem.
- 6 July 2023
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 38 (2) , 98-103
Open AccessFeatures of the management of elderly patients with non ST segment elevation myocardial infarction: analysis of risk factors, diagnosis and treatment strategy
Despite the technological developments in the healthcare industry, cardiovascular disease mortality occupies a leading place among the structure of general mortality of the population. The use of modern treatment methods, especially, percutaneous coronary intervention, provides timely assistance to patients with acute coronary syndrome and helps to reduce mortality frequency. Currently, clear algorithms for the management of patients with ST-segment elevation myocardial infarction have been developed. However, despite it, there are paradigms in the management of patients with non-ST-segment elevation myocardial infarction (NSTEMI). This is primarily due to the fact that the vast majority of patients with NSTEMI are elderly and senile persons. This review article presented the main factors that adversely affect short- and long-term prognosis and results of clinical studies dedicated to the study of this problem.
- 24 April 2023
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 18 (4)
Conduction disturbances after transcatheter aortic valve implantation
Aortic stenosis (AS) is the most common valvular disease in developed countries. Transcatheter aortic valve implantation (TAVI) is an efficient and safe procedure in the treatment of severe aortic stenosis with low risk of procedural complications. Indeed, accumulation of surgical experience has significantly reduced the incidence of procedural complications. However, high incidence of postoperative disorders of atrioventricular (AV) conduction is still a serious problem. This issue becomes even more important considering expansion of indications for TAVI in younger patients. This review is devoted to modern data on AV conduction disorders after TAVI and approaches to reducing the incidence of these complications.
- 24 April 2023
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 18 (4)
Conduction disturbances after transcatheter aortic valve implantation
Aortic stenosis (AS) is the most common valvular disease in developed countries. Transcatheter aortic valve implantation (TAVI) is an efficient and safe procedure in the treatment of severe aortic stenosis with low risk of procedural complications. Indeed, accumulation of surgical experience has significantly reduced the incidence of procedural complications. However, high incidence of postoperative disorders of atrioventricular (AV) conduction is still a serious problem. This issue becomes even more important considering expansion of indications for TAVI in younger patients. This review is devoted to modern data on AV conduction disorders after TAVI and approaches to reducing the incidence of these complications.
- Open Access
- 3 September 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (8) , 5164
Role of collateral circulation in maintaining and restoring the left ventricular function and modern methods for its assessment
The coronary blood flow plays an important role in protecting the myocardium from ischemia and maintaining the cardiomyocyte function in the event of occlusion of one of the epicardial arteries. It also has a potential for restoring the contractile function during subsequent myocardial revascularization, which requires its more detailed research. Most methods for assessing coronary collaterals are carried out to define the potential of their use for Retrograde chronic total occlusion recanalization. Currently, the most widely used method for assessing collateral blood flow is angiography, which, despite its relative simplicity and good knowledge, has following limitations: invasiveness, operator dependence, limited visualization, etc. At the same time, a number of other diagnostic methods can also be used to assess collateral flow. This review article is aimed at a detailed study of modern invasive and non-invasive methods for assessing the development and function of collateral vessels.
- 3 September 2022
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (8) , 5164
Open AccessRole of collateral circulation in maintaining and restoring the left ventricular function and modern methods for its assessment
The coronary blood flow plays an important role in protecting the myocardium from ischemia and maintaining the cardiomyocyte function in the event of occlusion of one of the epicardial arteries. It also has a potential for restoring the contractile function during subsequent myocardial revascularization, which requires its more detailed research. Most methods for assessing coronary collaterals are carried out to define the potential of their use for Retrograde chronic total occlusion recanalization. Currently, the most widely used method for assessing collateral blood flow is angiography, which, despite its relative simplicity and good knowledge, has following limitations: invasiveness, operator dependence, limited visualization, etc. At the same time, a number of other diagnostic methods can also be used to assess collateral flow. This review article is aimed at a detailed study of modern invasive and non-invasive methods for assessing the development and function of collateral vessels.
- Open Access
- 17 March 2022
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 11 (1) , 98-106-106
Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary interventions
Highlights. The article analyzes the current evidence base for anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary interventions, and future perspectives of such therapy.Abstract. A number of patients undergoing percutaneous coronary intervention may require intensification of antithrombotic therapy. These include patients with atrial fibrillation. The difficulty of treatment of this group of patients consists in the achievement of a certain level of hypocoagulation, which will be sufficient for the prevention of acute ischemic events, mainly associated with the implanted coronary stent, but will not lead to the clinically relevant bleeding. Achieving this balance requires a careful and personalized approach to prescribing a variety of combination (antiplatelet and anticoagulant) therapy regimens. The article provides an overview of modern antithrombotic therapy regimens in this group of patients, their evidence base and promising directions for improving such therapy.
- 17 March 2022
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 11 (1) , 98-106-106
Open AccessAntithrombotic therapy in patients with atrial fibrillation after percutaneous coronary interventions
Highlights. The article analyzes the current evidence base for anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary interventions, and future perspectives of such therapy.Abstract. A number of patients undergoing percutaneous coronary intervention may require intensification of antithrombotic therapy. These include patients with atrial fibrillation. The difficulty of treatment of this group of patients consists in the achievement of a certain level of hypocoagulation, which will be sufficient for the prevention of acute ischemic events, mainly associated with the implanted coronary stent, but will not lead to the clinically relevant bleeding. Achieving this balance requires a careful and personalized approach to prescribing a variety of combination (antiplatelet and anticoagulant) therapy regimens. The article provides an overview of modern antithrombotic therapy regimens in this group of patients, their evidence base and promising directions for improving such therapy.
- Open Access
- 19 June 2021
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 10 (2) , 72-83
Predictors to quality of life improvements in patients with chronic coronary total occlusion depending on the selected treatment strategy
Highlights. The impact of clinical, angiographic and procedure-related factors on the quality of life of patients with chronic coronary total occlusions has been reported.Background. The impact of patient-related factors including clinical and angiographic data and procedure-related factors on the quality of life remains debating.Aim. To assess the impact of baseline and procedure-related factors on the quality of life in patients with chronic coronary total occlusion.Methods. 140 patients with chronic single-vessel disease randomly assigned either to the invasive-strategy group or the conservative-strategy group. Quality of life was measured in all patients using the Seattle Angina Questionnaire, European Quality of Life Survey, and Rose Dyspnea Scale after 3 and 12 months. To determine the predictors to the quality of life improvements in both groups, simple and multivariate regression analysis were performed. The baseline clinical, angiographic and procedure-related factors were included in the analysis.Results. The technical success of the procedure was the independent predictor to quality of life improvement in the invasive-strategy group (OR: 5.8, 95%, CI: 3,26-9.18, p = 0.001). The absence of diabetes mellitus (OR: 0.19, 95%, CI: 0.09-0.84, p = 0.04), CTO of other than left anterior descending artery (OR: 2.1, 95%, CI: 1.09-4.0, p = 0.03) and higher SAQ - 7 score at baseline (OR: 1.1, 95%, CI: 1.04-1.21, p = 0.02) independently predicted the improvements in the quality of life. The indicators of quality of life between the subgroups of subintimal and intraluminal recanalization did not differ significantly in the long-term period. The total SAQ-7 score in the subintimal recanalization subgroup was 85.5 ± 9.1 versus 89.3 ± 9.6 in the intraluminal recanalization subgroup (p = 0.21).Conclusion. The decision on the management of patients with chronic coronary total occlusions should be made individually, taking into account baseline clinical and instrumental data. The recanalization technique does not affect the quality of life. Its choice should be made individually in order to achieve technical success.
- 19 June 2021
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 10 (2) , 72-83
Open AccessPredictors to quality of life improvements in patients with chronic coronary total occlusion depending on the selected treatment strategy
Highlights. The impact of clinical, angiographic and procedure-related factors on the quality of life of patients with chronic coronary total occlusions has been reported.Background. The impact of patient-related factors including clinical and angiographic data and procedure-related factors on the quality of life remains debating.Aim. To assess the impact of baseline and procedure-related factors on the quality of life in patients with chronic coronary total occlusion.Methods. 140 patients with chronic single-vessel disease randomly assigned either to the invasive-strategy group or the conservative-strategy group. Quality of life was measured in all patients using the Seattle Angina Questionnaire, European Quality of Life Survey, and Rose Dyspnea Scale after 3 and 12 months. To determine the predictors to the quality of life improvements in both groups, simple and multivariate regression analysis were performed. The baseline clinical, angiographic and procedure-related factors were included in the analysis.Results. The technical success of the procedure was the independent predictor to quality of life improvement in the invasive-strategy group (OR: 5.8, 95%, CI: 3,26-9.18, p = 0.001). The absence of diabetes mellitus (OR: 0.19, 95%, CI: 0.09-0.84, p = 0.04), CTO of other than left anterior descending artery (OR: 2.1, 95%, CI: 1.09-4.0, p = 0.03) and higher SAQ - 7 score at baseline (OR: 1.1, 95%, CI: 1.04-1.21, p = 0.02) independently predicted the improvements in the quality of life. The indicators of quality of life between the subgroups of subintimal and intraluminal recanalization did not differ significantly in the long-term period. The total SAQ-7 score in the subintimal recanalization subgroup was 85.5 ± 9.1 versus 89.3 ± 9.6 in the intraluminal recanalization subgroup (p = 0.21).Conclusion. The decision on the management of patients with chronic coronary total occlusions should be made individually, taking into account baseline clinical and instrumental data. The recanalization technique does not affect the quality of life. Its choice should be made individually in order to achieve technical success.